Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...
We have also recruited a luminary, Clinical Advisory Board, to help us anticipate and overcome real-life adoption hurdles ... higher interest expense related to our CRG term loan and higher expense ...
But instead of building on the close 2018 race, the Democrats’ nominee was blown away by nearly double digits. The defeat came notwithstanding that Democrats spent at least as much, if not more, than ...